Europe: Pharmaceuticals Industry Guide

Europe: Pharmaceuticals Industry Guide

Datamonitor's Europe: Pharmaceuticals Industry Guide is an essential resource for top-level data and analysis covering the Europe Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis with distinct chapters for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals

Scope of the Report

* Contains an executive summary and data on value, volume and segmentation for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals

* Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies

* Incorporates in-depth five forces competitive environment analysis and scorecards

* Includes five-year forecasts for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals

Highlights

The European biotechnology market had total revenue of $50.6 billion in 2009, representing a compound annual growth rate (CAGR) of 9% for the period spanning 2005-2009.

The European generics market had total revenue of $34.1 billion in 2009, representing a compound annual growth rate (CAGR) of 10.1% for the period spanning 2005-2009.

The European OTC pharmaceuticals market generated total revenues of $39.9 billion in 2009, representing a compound annual growth rate (CAGR) of 3% for the period spanning 2005-2009.

The European pharmaceuticals market is forecast to have total revenue of $195.6 billion in 2010, representing a compound annual growth rate (CAGR) of 4.3% for the period spanning 2006-2010.

Why you should buy this report

* Spot future trends and developments

* Inform your business decisions

* Add weight to presentations and marketing materials

* Save time carrying out entry-level research
TABLE OF CONTENTS
BIOTECHNOLOGY IN EUROPE 7
Market Overview 7
Market Value 9
Market Segmentation I 10
Market Segmentation II 11
Five Forces Analysis 12
Market Forecasts 20
GENERICS IN EUROPE 22
Market Overview 22
Market Value 24
Market Volume 25
Market Se